Table 5.
Univariate analysis and multivariate analysis data of adenocarcinoma patients complicated with DVT.
| Risk factor | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Stage III-IV | 4.776 (1.570-3.914) | .029 | 5.368 (1.871-18.165) | .021 |
| PD | 2.320 (.061-1.419) | .128 | 1.569 (.066-1.822) | .144 |
| Pericardial effusion | 1.088 (.028-2.983) | .297 | 1.254 (.081-1.949) | .872 |
| Pleural effusion | .089 (.160-12.059) | .765 | 2.040 (.173-2.399) | .571 |
| WBC (>9×109/L) | 6.003 (1.095-3.305) | .014 | 2.320 (.061-1.419) | .128 |
| CRP (>12 mg/L) | 4.964 (1.785-2.208) | .026 | 6.687 (1.967-13.617) | .010 |
| LDH (>300U/L) | .554 (.102-3.015) | .494 | 2.537 (.338-1.903) | .365 |
| NT-pro BNP (>300pg/ml) | 4.633 (1.343-5.406) | .031 | 5.575 (1.733-3.722) | .018 |
| D-dimer(>5 mg/L) | 5.841 (2.137-14.469) | .016 | 8.449 (4.323-18.536) | .004 |
| AT-III (<90%) | .710 (.048-3.353) | .400 | .968 (.036-3.008) | .328 |
| FDP (>6 mg/L) | 1.290 (.147-14.469) | .819 | 2.072 (.195-2.203) | .546 |
| CEA (>25 ng/ml) | 4.311 (1.197-5.104) | .038 | 4.755 (1.358-3.123) | .029 |